Question 1

Am I eligible to participate in this study based on my previous treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the An Extension Study of Telbivudine, Lamivudine or Telbivudine Plus Lamivudine in Patients With Chronic Hepatitis B clinical trial (NCT00124241). Contact the study team or your healthcare provider for specific answers.

Question 2

What are the potential side effects of telbivudine and lamivudine?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the An Extension Study of Telbivudine, Lamivudine or Telbivudine Plus Lamivudine in Patients With Chronic Hepatitis B clinical trial (NCT00124241). Contact the study team or your healthcare provider for specific answers.

Question 3

How does this treatment compare to other options available for chronic hepatitis B?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the An Extension Study of Telbivudine, Lamivudine or Telbivudine Plus Lamivudine in Patients With Chronic Hepatitis B clinical trial (NCT00124241). Contact the study team or your healthcare provider for specific answers.

Question 4

What will the study visits involve, and how often will I need to come in?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the An Extension Study of Telbivudine, Lamivudine or Telbivudine Plus Lamivudine in Patients With Chronic Hepatitis B clinical trial (NCT00124241). Contact the study team or your healthcare provider for specific answers.

Question 5

What happens if I experience side effects during the study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the An Extension Study of Telbivudine, Lamivudine or Telbivudine Plus Lamivudine in Patients With Chronic Hepatitis B clinical trial (NCT00124241). Contact the study team or your healthcare provider for specific answers.

Question 6

How will my progress be monitored during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the An Extension Study of Telbivudine, Lamivudine or Telbivudine Plus Lamivudine in Patients With Chronic Hepatitis B clinical trial (NCT00124241). Contact the study team or your healthcare provider for specific answers.

What this study is about